Global Atherectomy Devices Market Size and Share Analysis: Growth Trends and Forecast Report 2025–2033

Executive Summary

The Global Atherectomy Devices Market is projected to grow from US$ 1.05 billion in 2024 to US$ 2.21 billion by 2033, expanding at a CAGR of 8.63% during the forecast period (2025–2033). Key market drivers include the rising prevalence of Peripheral Artery Disease (PAD), a globally aging population, continuous technological advancements, and increasing adoption of minimally invasive procedures. As healthcare systems advance and reimbursement policies improve—especially in emerging economies—the demand for atherectomy devices is expected to grow significantly.

Download Sample & Read More: https://www.renub.com/request-sample-page.php?gturl=atherectomy-devices-market-p.php

 

Market Overview

What are Atherectomy Devices?

Atherectomy devices are advanced medical instruments used to remove plaque from arteries in patients suffering from coronary artery disease (CAD) and peripheral artery disease (PAD). These devices restore blood flow by either cutting, shaving, grinding, or vaporizing the arterial plaque, thereby alleviating symptoms such as angina or intermittent claudication. Their minimally invasive nature makes them a preferable alternative to traditional open surgeries.

The devices are broadly classified into:

  • Rotational Atherectomy Devices
  • Directional Atherectomy Devices
  • Orbital Atherectomy Devices
  • Laser Atherectomy Devices

Each of these types plays a unique role in treating varying plaque compositions and vessel sizes.

Market Dynamics

Key Market Drivers

  1. Rising Prevalence of PAD and Cardiovascular Diseases
  • PAD affects 8 to 12 million people in the United States alone, particularly those above 50 years.
  • Risk factors such as diabetes, obesity, smoking, and hypertension continue to rise, creating a massive patient pool requiring treatment.
  • Atherectomy devices offer a less invasive, effective solution for arterial plaque removal, improving long-term patient outcomes.
  1. Technological Advancements in Device Design
  • Real-time imaging integration (e.g., OCT, IVUS) enhances visualization and precision during procedures.
  • Enhanced ergonomics and user-friendly designs promote faster procedures and reduce operator fatigue.
  • Example: In August 2022, AngioDynamics’ Auryon Atherectomy System received 510(k) clearance for arterial thrombectomy, demonstrating innovation in the sector.
  1. Growing Aging Population
  • According to the U.S. Census (May 2023), there are 55.8 million elderly people (16.8% of the total population).
  • With age being a significant risk factor for atherosclerosis and PAD, this demographic trend supports sustained market growth.
  1. Expansion into Emerging Markets
  • Regions like Asia-Pacific, Latin America, and the Middle East are investing heavily in modern healthcare infrastructure.
  • Improved access to advanced care, increasing awareness, and rising disposable incomes further fuel market demand.

Market Challenges

  1. Lack of Skilled Operators
  • Atherectomy procedures require specialized training and clinical experience.
  • A shortage of trained professionals, especially in emerging economies, restricts the widespread adoption of these devices.
  1. High Device and Procedure Costs
  • Sophisticated technologies come at a premium. Hospitals may hesitate to invest due to budget constraints.
  • Patients in low-income regions often cannot afford these procedures, especially where reimbursement policies are weak or absent.

Regional Market Analysis

North America

United States

  • Leading the global market due to a robust healthcare system, rising elderly population, and increasing prevalence of PAD and atherosclerosis.
  • According to CDC (2024), nearly 25 million adults have high cholesterol—a major risk factor for arterial blockages.
  • Strong FDA pipeline approvals and active product launches further contribute to the market’s dynamism.

Canada

  • Growing investments in minimally invasive technologies and increasing cardiovascular disease rates are bolstering market expansion.

Europe

Germany

  • A strong healthcare system, coupled with favorable reimbursement policies, drives adoption.
  • High prevalence of diabetes, obesity, and cholesterol disorders contributes to increasing PAD cases.

United Kingdom, France, Italy, Spain

  • Widespread awareness of PAD and structured screening programs are fueling device demand.

Asia-Pacific

India

  • Rapidly increasing cases of cardiovascular disease due to urbanization, unhealthy diets, and sedentary lifestyles.
  • Government initiatives and a growing private healthcare sector are supporting technological adoption.

China & Japan

  • Significant investments in healthcare modernization and aging demographics make these countries key future growth hubs.

Middle East & Africa

Saudi Arabia

  • The rising burden of lifestyle diseases, coupled with strategic healthcare investments under Vision 2030, supports market growth.

UAE & South Africa

  • Surge in demand for advanced medical technologies and rising medical tourism in UAE positions the region as a growth market.

Segmentation Analysis

By Product Type

  • Directional Atherectomy Devices
  • Rotational Atherectomy Devices
  • Orbital Atherectomy Devices
  • Laser Atherectomy Devices

By Application

  • Cardiovascular
  • Neurovascular
  • Peripheral Vascular

By End User

  • Hospitals
  • Ambulatory Care Services
  • Medical Research Institutes

Competitive Landscape

Key Companies Profiled:

  1. Boston Scientific Corporation
  2. Abbott Laboratories
  3. Medtronic plc
  4. Cardinal Health
  5. Terumo Corporation
  6. Integer Holdings Corporation
  7. Becton, Dickinson and Company
  8. AngioDynamics Inc.

Each company has been analyzed based on:

  • Company Overview
  • Key Executives
  • Product Portfolio
  • Recent Developments & Strategies
  • Revenue Analysis

Forecast Period Outlook (2025–2033)

  • Market value expected to nearly double by 2033.
  • Expansion driven by technological innovation, growing geriatric population, and healthcare investment.
  • Increasing collaborations and strategic acquisitions likely to shape future competition.

Customization Services Available

We offer:

  • Region-Specific Market Dynamics
  • Market Entry Strategies
  • Trade and Production Insights
  • Additional Company or Country Profiles
  • 20% Free Customization
  • 1-Year Analyst Support

Report Details

Feature Details
Base Year 2024
Forecast Period 2025–2033
Market Coverage US$ Billion
Segments Covered Product Type, Application, End User, Countries
Delivery Format PDF & Excel (Editable upon request)
Customization Scope 20% Free
Post-Sale Support 1 Year (52 Weeks)

Frequently Asked Questions (FAQs)

Q1: What is the current market size of the Atherectomy Devices industry?
A: The global atherectomy devices market was valued at US$ 1.05 billion in 2024.

Q2: What is the expected market value by 2033?
A: The market is projected to reach US$ 2.21 billion by 2033.

Q3: What is the CAGR for the forecast period 2025–2033?
A: The market is expected to grow at a CAGR of 8.63%.

Q4: Which regions are expected to witness the fastest growth?
A: Asia-Pacific and the Middle East are poised for the highest growth due to rising healthcare investments and disease prevalence.

Q5: What are the major challenges in this market?
A: High cost of devices and lack of skilled professionals are significant barriers.

Contact Us

📞 USA: +1-678-302-0700
📞 India: +91-120-421-9822
📧 Email: [email protected]
🌐 www.renub.com

 

Categorized in:

Business,

Last Update: April 9, 2025